🇺🇸 FDA

Drug profile · INN

trametinib dimethyl sulfoxide

MEKINIST INITIAL APPROVAL

FDA: approved PMDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

trametinib dimethyl sulfoxide (MEKINIST INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN trametinib dimethyl sulfoxide
Brand MEKINIST INITIAL APPROVAL
Route ORAL
Formulation SOLUTION

Frequently asked questions

What is trametinib dimethyl sulfoxide?

trametinib dimethyl sulfoxide (MEKINIST INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for trametinib dimethyl sulfoxide?

MEKINIST INITIAL APPROVAL is a marketed brand name for trametinib dimethyl sulfoxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of trametinib dimethyl sulfoxide?

trametinib dimethyl sulfoxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.